The type III pseudomonal exotoxin U activates the c-Jun NH2-terminal kinase pathway and increases human epithelial interleukin-8 production

被引:27
作者
Cuzick, Alayne
Stirling, Fiona R.
Lindsay, Susan L.
Evans, Thomas J. [1 ]
机构
[1] Univ Glasgow, Western Infirm, Div Immunol Infect & Inflammat, Glasgow G11 6NT, Lanark, Scotland
[2] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis, London, England
基金
英国惠康基金;
关键词
D O I
10.1128/IAI.02045-05
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Microbial interactions with host cell signaling pathways are key determinants of the host cell response to infection. Many toxins secreted by bacterial type III secretion systems either stimulate or inhibit the host inflammatory response. We investigated the role of type III secreted toxins of the lung pathogen Pseudomonas aeruginosa in the inflammatory response of human respiratory epithelial cells to infection. Using bacteria with specific gene deletions, we found that interleukin-8 production by these cells was almost entirely dependent on bacterial type III secretion of exotoxin U (ExoU), a phospholipase, although other bacterial factors are involved. ExoU activated the c-Jun NH2-terminal kinase pathway, stimulating the phosphorylation and activation of mitogen-activated kinase kinase 4, c-jun NH2-terminal kinase, and c-jun. This in turn increased levels of transcriptionally competent activator protein-1. Although this pathway was dependent on the lipase activity of ExoU, it was independent of cell death. Activation of mitogen-activated kinase signaling by ExoU in this fashion is a novel mechanism by which a bacterial product can initiate a host inflammatory response, and it may result in increased epithelial permeability and bacterial spread.
引用
收藏
页码:4104 / 4113
页数:10
相关论文
共 65 条
  • [1] Seven-year study of bacteraemic pneumonia in a single institution
    Bishara, J
    Leibovici, L
    Ashkenazi, S
    Samra, Z
    Pitlik, S
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (12) : 926 - 931
  • [2] Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential
    Bogoyevitch, MA
    Boehm, I
    Oakley, A
    Ketteman, AJ
    Barr, RK
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1697 (1-2): : 89 - 101
  • [3] INFLAMMATORY CYTOKINES IN CYSTIC-FIBROSIS LUNGS
    BONFIELD, TL
    PANUSKA, JR
    KONSTAN, MW
    HILLIARD, KA
    HILLIARD, JB
    GHNAIM, H
    BERGER, M
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (06) : 2111 - 2118
  • [4] Direct biochemical evidence for type III secretion-dependent translocation of the AvrBs2 effector protein into plant cells
    Casper-Lindley, C
    Dahlbeck, D
    Clark, ET
    Staskawicz, BJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) : 8336 - 8341
  • [5] Ventilator-associated pneumonia
    Chastre, J
    Fagon, JY
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (07) : 867 - 903
  • [6] Assembly and function of type III secretory systems
    Cornelis, GR
    Van Gijsegem, F
    [J]. ANNUAL REVIEW OF MICROBIOLOGY, 2000, 54 : 735 - 774
  • [7] Role of the cystic fibrosis transmembrane conductance regulator in internalization of Pseudomonas aeruginosa by polarized respiratory epithelial cells
    Darling, KEA
    Dewar, A
    Evans, TJ
    [J]. CELLULAR MICROBIOLOGY, 2004, 6 (06) : 521 - 533
  • [8] Effects of nitric oxide on Pseudomonas aeruginosa infection of epithelial cells from a human respiratory cell line derived from a patient with cystic fibrosis
    Darling, KEA
    Evans, TJ
    [J]. INFECTION AND IMMUNITY, 2003, 71 (05) : 2341 - 2349
  • [9] The innate immune response of the respiratory epithelium
    Diamond, G
    Legarda, D
    Ryan, LK
    [J]. IMMUNOLOGICAL REVIEWS, 2000, 173 : 27 - 38
  • [10] DIVERSE PSEUDOMONAS-AERUGINOSA GENE-PRODUCTS STIMULATE RESPIRATORY EPITHELIAL-CELLS TO PRODUCE INTERLEUKIN-8
    DIMANGO, E
    ZAR, HJ
    BRYAN, R
    PRINCE, A
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) : 2204 - 2210